{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2017"],"condition":["Colorectal Cancer","Colonic Neoplasms"],"data_sharing_plan":["IPD Sharing (as of April 2018): Yes"],"disease":["Colorectal Cancer","Colonic Neoplasms"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2271350"],"location":["Vietnam"],"study_start_month":["1"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI","description":"Colon cancer with metastase in the diagnose time account for one significant rate and has a increasing trend. The treatment result of this patient group rests modest. The biological therapeutic treatment is still expensive for major part of Vietnamese patients. So that, research on a new affordable and efficacious chemotherapy combination for these patients is extremely necessary in our country The purpose of the study is to comment somes clinico-pathology features of metastatic colon cancer patients whose disease was not radically resectable.\nThe second aim is to Evaluate the treatment result and toxicity of FOLFOXIRI in these patients","dates":{"creation":"2017-01-15"},"accession":"2271350","cross_references":{"ClinicalTrials___gov":["NCT03504618"]}}